The impact of endoscopic ultrasonography with fine needle aspiration (EUS-FNA) on esophageal cancer staging: A survey of thoracic surgeons and gastroenterologists

Diseases of the Esophagus

Volumn 21, Issue 6, 2008, Pages 480-487

  Maple, John T ^a   Peifer, K J ^b   Edmundowicz, S A ^c   Early, D S ^c   Meyers, B F ^c   Jonnalagadda, S ^c   Azar, R R ^c  

^a UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^b Rockford Gastroenterology Associates   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Endosonography; Esophageal neoplasms; Neoplasm staging

Indexed keywords

ARTICLE; ASPIRATION BIOPSY; CANCER STAGING; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; ENDOSCOPIC ECHOGRAPHY; ESOPHAGUS CANCER; ESOPHAGUS DILATATION; ESOPHAGUS RESECTION; ESOPHAGUS STRICTURE; HEALTH CARE QUALITY; HEALTH CARE UTILIZATION; HEALTH SURVEY; HUMAN; LYMPH NODE; MEDICAL SPECIALIST; PEER GROUP; PHYSICIAN ATTITUDE; PRIORITY JOURNAL; THORAX SURGERY;

ADULT; BIOPSY, FINE-NEEDLE; EARLY DIAGNOSIS; ENDOSONOGRAPHY; ESOPHAGEAL NEOPLASMS; FEMALE; GASTROENTEROLOGY; HEALTH CARE SURVEYS; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PHYSICIAN'S PRACTICE PATTERNS; QUESTIONNAIRES; SENSITIVITY AND SPECIFICITY; THORACIC SURGERY; UNITED STATES;

EID: 51249103382     PISSN: 11208694     EISSN: 14422050     Source Type: Journal    
DOI: 10.1111/j.1442-2050.2007.00804.x     Document Type: Article

References (26)

1. Ries L A G, Harkins D, Krapcho M et al. SEER Cancer Statistics Review, 1975-2003. Bethesda, MD: National Cancer Institute. http://seer.cancer.gov/csr/1975_2003/, based on November 2005 SEER data submission, posted to the SEER web site 2006.
2. Enzinger P C, Mayer R J. Esophageal cancer. New Engl J Med 2003; 349: 2241-52.
3. Van Westreenen H L, Westerterp M, Bossuyt P M M et al. Systematic review of the staging performance of 18 F-fluorodeoxyglucose positron emission tomography in esophageal cancer. J Clin Oncol 2004; 22: 3805-12.
4. Rosch T. Endosonographic staging of esophageal cancer: A review of the literature results. Gastrointest Endosc Clin N Am 1995; 5: 537-48.
5. Vazquez-Sequeiros E, Wiersema M J, Clain J E et al. Impact of lymph node staging on therapy of esophageal carcinoma. Gastroenterology 2003; 125: 1626-35.
6. Kim L S, Loch J. Do we practice what we preach? Clinical decision making and utilization of endoscopic ultrasound for staging esophageal cancer. Am J Gastroenterol 1999; 94: 1847-52.
7. McClave S A, Jones W F, Evans W B. Do physician attitudes and practices limit use of EUS in the staging and treatment of esophageal carcinoma? Gastrointest Endosc 2005; 61: 840-8.
8. Shumaker D A, de Garmo P, Faigel D O. Potential impact of preoperative EUS on esophageal cancer management and cost. Gastrointest Endosc 2002; 56: 391-6.
9. Nickl N, Bhutani M, Catalano M et al. Clinical implications of endoscopic ultrasound: The American Endosonography Club Study. Gatrointest Endosc 1996; 44: 371-7.
10. Mallery S, Van Dam J. EUS in the evaluation of esophageal carcinoma. Gastrointest Endosc 2000; 52: S6-11.
11. Vazquez-Sequeiros E, Norton I D, Clain J E et al. Impact of EUS-guided fine-needle aspiration on lymph node staging in patients with esophageal carcinoma. Gastrointest Endosc 2001; 53: 751-7.
12. Flamen P, Lerut A, van Cutsem E et al. Utility of positron emission tomography for the staging of patients with potentially operable esophageal carcinoma. J Clin Oncol 2000; 18: 3202-10.
13. Rice T W. Clinical staging of esophageal carcinoma: CT, EUS, PET. Chest Surg Clin N Am 2000; 10: 471-85.
14. Ahmad N A, Kochman M L, Ginsberg G G. Practice patterns and attitudes toward the role of endoscopic ultrasound in staging of gastrointestinal malignancies: A survey of physicians and surgeons. Am J Gastroenterol 2005; 100: 2662-8.
15. Van Dam J, Rice T W, Catalano M F et al. High-grade malignant stricture is predictive of esophageal tumor stage. Risks of endosonographic evaluation. Cancer 1993; 71: 2910-7.
16. Catalano M F, Van Dam J, Sivak M V. Malignant esophageal strictures: staging accuracy of endoscopic ultrasonography. Gastrointest Endosc, 1995; 41: 535-9.
17. Kallimanis G E, Gupta P K, al-Kawas F H et al. Endoscopic ultrasound for staging esophageal cancer, with or without dilation, is clinically important and safe. Gastrointest Endosc 1995; 41: 540-6.
18. Pfau P R, Ginsberg G G, Lew R J et al. Esophageal dilation for endosonographic evaluation of malignant esophageal strictures is safe and effective. Am J Gastroenterol 2000; 95: 2813-5.
19. Wallace M B, Hawes R H, Sahai A V, van Velse A, Hoffman B J. Dilation of malignant esophageal stenosis to allow EUS-guided fine-needle aspiration: Safety and effect on patient management. Gastrointest Endosc 2000; 51: 309-13.
20. American Joint Committee on Cacner. AJCC Cancer Staging Manual, 6th edn. New-York: Springer-Verlag, 2002.
21. Clinical Practice Guidelines in Oncology-Esophageal Cancer v.22007. National Comprehensive Cancer Network. Available at: http://www.nccn.org/ professionals/physician_gls/PDF/esophageal.pdf. Accessed August27, 2007.
22. Christie N A, Rice T W, DeCamp M M et al. M1a/M1b esophageal carcinoma: clinical relevance. J Thorac Cardiovasc Surg 1999; 118: 900-7.
23. Marsman W A, van Wissen M, Bergman J J et al. Outcome of patients with esophageal carcinoma and suspicious celiac lymph nodes as determined by endoscopic ultrasonography. Endoscopy 2004; 36: 961-5.
24. Eloubeidi M A, Wallace M B, Hoffman B J et al. Predictors of survival for esophageal cancer patients with and without celiac axis lymphadenopathy: Impact of staging endosono-graphy. Ann Thorac Surg 2001; 72: 212-20.
25. Malaisrie S C, Hofstetter W L, Correa A M et al. Endoscopic ultrasonography-identified celiac adenopathy remains a poor prognostic factor despite preoperative chemoradiotherapy in esophageal adenocarcinoma. J Thorac Cardiovasc Surg 2006; 131: 65-72.
26. Frizzell B, Sinha D, Williams T, Reed C E, Sherman C A, Turrisi A. Influence of celiac axis lymph nodes in the definitive treatment of esophageal cancer. Am J Clin Oncol 2003; 26: 215-20.